UP - logo

Search results

Basic search    Advanced search   
Search
request
Library

Currently you are NOT authorised to access e-resources UPUK. For full access, REGISTER.

1 2
hits: 16
1.
  • Farmakogenomika i farmakovi... Farmakogenomika i farmakovigilancija
    Božina, Nada Medicus (Zagreb, Croatia : 1992), 07/2017, Volume: 26, Issue: 1 Farmakovigilancija
    Journal Article
    Peer reviewed
    Open access

    Razvoj nove discipline farmakogenetike/farmakogenomike omogućio je bolje razumijevanje genetičke predispozicije za razvoj neočekivanih reakcija na primijenjeni lijek i posljedično unaprijedio ...
Full text
2.
  • Treatment Resistance« Enigm... Treatment Resistance« Enigma Resolved by Pharmacogenomics − A Case Study of Clozapine Therapy in Schizophrenia / Enigma »Terapo-Rezistence« Razrešena Uz Pomoć Farmakogenomike - Prikaz Slućaja Terapije Klozapinom U Shizofreniji
    Maric, Nadja P; Nikolic, Slobodanka Pejovic; Buzadzic, Ivan a ... Journal of medical biochemistry, 4/2015, Volume: 34, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    The introduction of antipsychotic medication in the 1950s forever changed the outlook on the treatment of schizophrenia, although there is still a large proportion of patients who do not reach ...
Full text

PDF
3.
  • Influence Of Promoter Polym... Influence Of Promoter Polymorphisms Of The Tnf-α (-308g/A) And IL-6 (-174g/C) Genes On Therapeutic Response To Etanercept In Rheumatoid Arthritis
    Jančić, Ivan; Šefik-Bukilica, Mirjana; Živojinović, Slađana ... Journal of medical biochemistry, 10/2015, Volume: 34, Issue: 4
    Journal Article
    Peer reviewed
    Open access

    The study was undertaken to assess the influence of functional -308G/A TNF-α (rs 1800629) and -174G/C IL-6 (rs1800795) promoter polymorphisms on the therapeutic response to etanercept, a TNF-α ...
Full text

PDF
4.
Full text

PDF
5.
Full text

PDF
6.
  • The Association of OGG1 Ser... The Association of OGG1 Ser326Cys Polymorphism and Urinary 8-OHdG Levels With Lung Cancer Susceptibility: A Hospital-Based Case-Control Study in Turkey
    Karahalil, Bensu; Emerce, Esra; Koçer, Bülent ... Arhiv za higijenu rada i toksikologiju, 12/2008, Volume: 59, Issue: 4
    Journal Article
    Peer reviewed
    Open access

    High incidence and poor prognosis of lung cancer make it a major health problem worldwide. Although smoking is a major cause of lung cancer, only some smokers develop lung cancer, which suggests that ...
Full text

PDF
7.
  • Farmakogenomika: značenje z... Farmakogenomika: značenje za medicinu u sljedećim desetljećima
    Topić, Elizabeta; Primorac, Dragan Zbornik sveučilišta Libertas, 10/2019, Volume: 4, Issue: 4
    Journal Article
    Open access

    Bez sumnje je da budućnost medicine stremi ka vrhunskim metodama rane dijagnostike i individualno dizajniranom liječenju, stoga je Komisija EU 2016. među svoje ključne prioritete u zdravstvu uvrstila ...
Full text
8.
  • Kako polimorfizmi gena cito... Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost ibuprofena i diklofenaka
    Krasniqi, Valon; Dimovski, Aleksandar; Klarica Domjanović, Iva ... Arhiv za higijenu rada i toksikologiju, 03/2016, Volume: 67, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Interindividualne razlike u metabolizmu mogu biti važan čimbenik nastanka nuspojava te varijabilnosti u učinkovitosti lijeka. Polimorfizmi gena koji kodiraju metaboličke enzime citokrome P450 (CYP) ...
Full text

PDF
9.
  • Farmakogenetika depresija Farmakogenetika depresija
    Henigsberg, Neven; Folnegović-Šmalc, Vera Medicus (Zagreb, Croatia : 1992), 01/2004, Volume: 13, Issue: 1_Depresija
    Journal Article
    Peer reviewed
    Open access

    Farmakogenetika, a posebno farmakogenomika, nove su znanstvene discipline čiji početni rezultati daju nadu da će se među bolesnicima koji boluju od depresije uspjeti prepoznati homogene skupine s ...
Full text
10.
  • Farmakogenetika varfarina u... Farmakogenetika varfarina u kliničkoj praksi
    Božina, Nada Biochemia medica, 02/2010, Volume: 20, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Varfarin je najpropisivaniji oralni antikoagulans. Postoje velike interindividualne razlike (i do 20 puta) u potrebnim dozama lijeka, štoje rezultat genetičkih i okolišnih čimbenika. Podaci dobiveni ...
Full text
1 2
hits: 16

Load filters